Try a new search

Format these results:

Searched for:

person:sarnod01

Total Results:

33


Current concepts in the management of actinic keratosis

Hale, Elizabeth K; Jorizzo, Joseph L; Nehal, Kishwer S; Perez, Maritza I; Robins, Perry; Sarnoff, Deborah
PMID: 15113084
ISSN: 1545-9616
CID: 46175

Objective and quantitative improvement of rosacea-associated erythema after intense pulsed light treatment

Mark, Kenneth A; Sparacio, Rose Marie; Voigt, Audra; Marenus, Kenneth; Sarnoff, Deborah S
BACKGROUND: Despite the widespread and quite successful use of various lasers and light sources to treat facial erythema, the literature contains little, if any, objective and quantitative improvement. In addition, very few studies specifically address rosacea-associated erythema. OBJECTIVE: To assess quantitatively the degree of improvement in patients with rosacea after intense pulsed light treatment. The three main parameters that were objectively measured were blood flow, telangiectasia, and erythema. METHODS: Four patients with rosacea-associated erythema and telangiectasia were treated five times at 3-week intervals with the Photoderm VL (Lumenis, Needham, MA). The 515-nm filter, a single pulse duration of 3 ms, and various fluences were used. Blood flow was measured by the scanning laser Doppler. Close-up photography ensured reproducibility and enabled quantification of telangiectasia and erythema by subsequent computer image analysis. Measurements were taken at baseline and at 1 month after the last treatment. RESULTS: The scanning laser Doppler demonstrated a 30% decrease in blood flow (P<0.05). A 29% decrease in actual area of the cheek occupied by telangiectasia was noted (P<0.05). A 21% decrease in the intensity of erythema was noted (P<0.05). CONCLUSION: As demonstrated by truly objective and quantitative means, intense pulsed light is effective for reducing rosacea-associated blood flow, telangiectasia, and erythema
PMID: 12786702
ISSN: 1076-0512
CID: 39210

Suture-assisted resurfacing of the acne-scarred face

Sarnoff, Deborah S; Gotkin, Robert H
In the authors' experience, surgical repair of pitted scars, performed in conjunction with CO(2) laser resurfacing, produces no linear scars visible to the naked eye on the skin surface. Here, they describe their single-stage technique, suture-assisted resurfacing, in which, one-by-one, each ice-pick scar is incised with a triple bevel NoKor 18-gauge needle. (Aesthetic Surg J 2002;22:284-288.)
PMID: 19331981
ISSN: 1527-330x
CID: 141662

In favor of antibiotic prophylaxis for laser resurfacing [4]

Mark KA; Sarnoff DS
EMBASE:2001323527
ISSN: 0003-987x
CID: 26873

Squamous cell carcinoma and actinic keratosis

Chapter by: Mark KA; Sarnoff DS
in: Current dermatologic diagnosis & treatment by Freedberg IM; Sanchez MR [Eds]
Philadelphia : Lippincott Williams & Wilkins, 2001
pp. 200-201
ISBN: 0781735319
CID: 3760

Goodbye, managed care; hello, skin care

Sarnoff DS
PMID: 10566828
ISSN: 0003-987x
CID: 6241

Pulsed dye laser treatment of molluscum contagiosum in a patient with acquired immunodeficiency syndrome [Case Report]

Nehal KS; Sarnoff DS; Gotkin RH; Friedman-Kien A
BACKGROUND: Molluscum contagiosum is usually a self-limited benign viral disease in children and young adults. In patients with acquired immunodeficiency syndrome (AIDS), however, the infection is often widespread, disfiguring, and recalcitrant to conventional therapy. OBJECTIVE: A treatment modality for widespread, recurrent molluscum contagiosum is necessary that is effective, safe, and simple. METHODS: Widespread molluscum contagiosum recalcitrant to conventional therapy in a patient with AIDS was treated with the 585-nm pulsed dye laser. RESULTS: There was a significant reduction in the number of molluscum contagiosum lesions following a single treatment with the pulsed dye laser. Treated-areas remained disease-free after 4 months. No complications were associated with the procedure. CONCLUSION: Pulsed dye laser treatment may offer another therapeutic modality that is effective and safe in the treatment of widespread and recurrent molluscum contagiosum
PMID: 9598007
ISSN: 1076-0512
CID: 7704

Treatment and prevention of basal cell carcinoma with oral isotretinoin

Peck GL; DiGiovanna JJ; Sarnoff DS; Gross EG; Butkus D; Olsen TG; Yoder FW
Twelve patients with multiple basal cell carcinomas resulting from varying causes were treated with high-dose oral isotretinoin (mean daily dosage: 3.1 mg/kg/day) for a mean of 8 months. Of the 270 tumors monitored in these patients, only 8% underwent complete clinical and histologic regression. All patients developed moderate to severe acute toxicities, leading five patients to withdraw from the study. Retinoid skeletal toxicity was identified in two patients who were examined after long-term therapy. Lower doses of isotretinoin (0.25 to 1.5 mg/kg/day) were ineffective for chemotherapy but demonstrated a chemopreventive effect in a subset of three patients who received these lower doses for 3 to 8 years. Two of these three patients have been observed after discontinuation of therapy. In one patient with a history of arsenic exposure, only one new tumor has appeared in a 27-month posttreatment observation period; in the other patient with the nevoid basal cell carcinoma syndrome, 29 new tumors have appeared within a 13-month period. This suggests that the need for long-term maintenance therapy with isotretinoin for chemoprevention of basal cell carcinoma may depend on the underlying cause of the skin cancers
PMID: 3165982
ISSN: 0190-9622
CID: 16914

Where's the spot?

Robins P; Sarnoff DS
PMID: 3782595
ISSN: 0148-0812
CID: 16879

MOHS SURGERY [Letter]

SARNOFF, DS; ROBINS, P
ISI:A1986E353300021
ISSN: 0193-1091
CID: 41345